---
title: "VRNA.US (VRNA.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/VRNA.US/news.md"
symbol: "VRNA.US"
name: "VRNA.US"
parent: "https://longbridge.com/en/quote/VRNA.US.md"
datetime: "2026-05-21T15:06:10.886Z"
locales:
  - [en](https://longbridge.com/en/quote/VRNA.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/VRNA.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/VRNA.US/news.md)
---

# VRNA.US (VRNA.US) — Related News

### [Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma | ACHV Stock News](https://longbridge.com/en/news/286088273.md)
*2026-05-12T03:05:00.000Z*
> Achieve Life Sciences has announced three senior appointments: Christopher Martin joins the Board of Directors, while Ma

### [Verana Health Transforms Site Selection and Patient Enrollment in Clinical Trials](https://longbridge.com/en/news/285217308.md)
*2026-05-05T13:17:40.000Z*
> Verana Health®, a digital health company based in San Francisco, announced on May 5, 2026, that sponsors and CROs will n

### [New Verana Health AI Agent Boosts Efficiency and Compliance in MIPS Submissions](https://longbridge.com/en/news/284404568.md)
*2026-04-28T13:52:16.000Z*
> Agent Claire is enabling clinicians to make quicker decisions, lower risk, and enhance operational efficiency. On April 

### [Verana Health and Guardant Health Partner to Advance Precision Medicine with Real-World Data | GH Stock News](https://longbridge.com/en/news/280324039.md)
*2026-03-24T05:15:44.000Z*
> Verana Health and Guardant Health Partner to Advance Precision Medicine with Real-World Data | GH Stock News

### [13:00 ETArna Pharma Inc. and Slate Run Pharmaceuticals to form a Joint Venture to Create Scaled-Up U.S. Specialty Pharmaceutical Platform](https://longbridge.com/en/news/277080888.md)
*2026-02-26T18:02:17.000Z*
> Arna Pharma Inc. and Slate Run Pharmaceuticals have signed a Memorandum of Understanding (MOU) to establish a joint vent

### [Cantor Fitzgerald Reiterates "Overweight" Rating for Verona Pharma PLC American Depositary Share (NASDAQ:VRNA)](https://longbridge.com/en/news/260298575.md)
*2025-10-08T14:30:11.000Z*
> Cantor Fitzgerald has reaffirmed an "overweight" rating for Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) wi

### [Cantor Fitzgerald Remains a Buy on Verona Pharma (VRNA)](https://longbridge.com/en/news/260282428.md)
*2025-10-08T12:16:35.000Z*
> According to TipRanks, Brayer is a 3-star analyst with an average return of 4.4% and a 40.98% success rate. Brayer cover

### [Verona Pharma Completes Acquisition and Delisting Process](https://longbridge.com/en/news/260154801.md)
*2025-10-07T11:29:28.000Z*
> Verona Pharma has completed its acquisition process, sanctioned by the High Court of Justice of England and Wales on Oct

### [](https://longbridge.com/en/news/260149371.md)
*2025-10-07T10:46:42.000Z*
> Market news: Merck has completed the acquisition of Verona Pharma